Castration-Resistant Prostate Carcinoma

Castration-Resistant Prostate Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

554 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 223
Recruiting: 123
Ph III recruiting: 12
Growth YoY: +27.5%
Industry share: 45%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (94)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04222634	Metastasis-directed Therapy in Castration-refractory Prostate Cancer(MEDCARE)	active not recruiting	N/A	18	Universitaire Ziekenhuizen KU LeuvenOTHER	1	Dec 7, 2023	clinicaltrials

Data updated 23 days agoSource updated Dec 7, 2023source: clinicaltrials